Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 12, 2013

Hisamitsu, ImmunoCellular Therapeutics, Kyowa Hakko Kirin, Lupin, Mallinckrodt, Medivir, Naurex, Orexo, Synta

Preclinical
Naurex demonstrates mechanism of rapid antidepressant . . . read more

Phase II
ImmunoCellular misses endpoint in GBM . . . read more

Medivir begins combo trial against HCV . . . read more

Synta posts interim results in breast cancer . . . read more

Phase III
Celator DSMB clears AML trial . . . read more

Mallinckrodt meets endpoint with pain XR trial . . . read more

Launches
Lupin launches generic Cymbalta . . . read more

Orexo partner launches Abstral in Japan . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters